Scientists have engineered bacteria to turn waste plastic bottles into the Parkinson’s disease drug L-DOPA

Researchers engineered a two-strain microbial system that converts PET-derived terephthalic acid into levodopa, overcoming key bottlenecks in transport and enzyme inhibition. The proof-of-concept process achieves high yields under mild conditions and demonstrates a potential route for upcycling plastic waste into valuable pharmaceuticals.